Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Porschen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Colorectal Disease|February 18, 2009
Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery aloneOliver Nehls, Holger G Hass, Thomas Okech, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trialsHendrik-Tobias Arkenau, Dirk Arnold, Jim Cassidy, et al.
Clinical Colorectal Cancer|February 19, 2008
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancerHendrik-Tobias Arkenau, Ullrich Graeven, Stephan Kubicka, et al.
Oncotarget|March 15, 2018
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysisChristine Koch, Anna M Schwing, Eva Herrmann, et al.
Oncology Research and Treatment|June 1, 2025
Guidelines of Onkopedia: What Is New?Magdalena K Scheck, Salah-Eddin Al-Batran, Markus Borner, et al.
The New England Journal of Medicine|January 6, 2012
TFAP2E-DKK4 and chemoresistance in colorectal cancerMatthias P A Ebert, Marc Tänzer, Benjamin Balluff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD DatabaseLindsay A Renfro, Fotios Loupakis, Richard A Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system databaseQian Shi, Aimery de Gramont, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive DatabaseLindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Colorectal Disease|February 18, 2009
Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery aloneOliver Nehls, Holger G Hass, Thomas Okech, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trialsHendrik-Tobias Arkenau, Dirk Arnold, Jim Cassidy, et al.
Clinical Colorectal Cancer|February 19, 2008
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancerHendrik-Tobias Arkenau, Ullrich Graeven, Stephan Kubicka, et al.
Oncotarget|March 15, 2018
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysisChristine Koch, Anna M Schwing, Eva Herrmann, et al.
Oncology Research and Treatment|June 1, 2025
Guidelines of Onkopedia: What Is New?Magdalena K Scheck, Salah-Eddin Al-Batran, Markus Borner, et al.
The New England Journal of Medicine|January 6, 2012
TFAP2E-DKK4 and chemoresistance in colorectal cancerMatthias P A Ebert, Marc Tänzer, Benjamin Balluff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD DatabaseLindsay A Renfro, Fotios Loupakis, Richard A Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system databaseQian Shi, Aimery de Gramont, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive DatabaseLindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.
Pageof 4